Cargando…

Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers

Immune checkpoint inhibitors (ICI) are highly effective in specific cancers where canonical markers of antitumor immunity are used for patient selection. Improved predictors of T cell-inflammation are needed to identify ICI-responsive tumor subsets in additional cancer types. We investigated associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero, Joan Miguel, Titmuss, Emma, Wang, Yifan, Vafiadis, James, Pacis, Alain, Jang, Gun Ho, Zhang, Amy, Golesworthy, Bryn, Lenko, Tatiana, Williamson, Laura M., Grünwald, Barbara, O’Kane, Grainne M., Jones, Steven J. M., Marra, Marco. A., Wilson, Julie M., Gallinger, Steven, Laskin, Janessa, Zogopoulos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412582/ https://www.ncbi.nlm.nih.gov/pubmed/37558751 http://dx.doi.org/10.1038/s41698-023-00428-2

Ejemplares similares

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
por: Golesworthy, Bryn, et al.
Publicado: (2022)

Avancées dans la prise en charge de l’adénocarcinome canalaire pancréatique
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

TMBur: a distributable tumor mutation burden approach for whole genome sequencing
por: Titmuss, Emma, et al.
Publicado: (2022)

Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy
por: Zhang, Yiqun, et al.
Publicado: (2021)

The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer
por: Duan, Kai, et al.
Publicado: (2021)

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma
por: Topham, James T., et al.
Publicado: (2022)

Determinants of gemcitabine response in pancreatic cancer: are we there?
por: Fitzpatrick, Orla M., et al.
Publicado: (2023)

Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways
por: Lavoie, Jean-Michel, et al.
Publicado: (2022)

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration
por: Tsang, Erica S., et al.
Publicado: (2023)

Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant
por: Majounie, Elisa, et al.
Publicado: (2020)

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2021)

Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis
por: Holzapfel, Nicholas, et al.
Publicado: (2023)

A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene
por: Wong, Cavin, et al.
Publicado: (2019)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
por: Barnes, Tristan A., et al.
Publicado: (2017)

Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists
por: Chow-White, Peter, et al.
Publicado: (2017)

Evidence for chemokine synergy during neutrophil migration in ARDS
por: Williams, Andrew E, et al.
Publicado: (2017)

The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system
por: Wong, Derek, et al.
Publicado: (2019)

Matching methods in precision oncology: An introduction and illustrative example
por: Weymann, Deirdre, et al.
Publicado: (2020)

Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
por: Weymann, Deirdre, et al.
Publicado: (2021)

Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury
por: Williamson, Laura M., et al.
Publicado: (2021)

Locally Advanced Cutaneous Squamous Cell Carcinoma: Two Case Reports of Dramatic Responses to Sequential Cisplatin, Docetaxel and Radiotherapy
por: Dennis, Kristopher E., et al.
Publicado: (2011)

Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature
por: Lee, Cha Len, et al.
Publicado: (2022)

Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities
por: Wang, Yifan, et al.
Publicado: (2020)

A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy
por: Geller, Georgia, et al.
Publicado: (2017)

Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies
por: Guimond, Elizabeth, et al.
Publicado: (2022)

Molecular characterization of ERBB2-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive cases
por: Owen, Daniel R., et al.
Publicado: (2018)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Germline EPHB2 Receptor Variants in Familial Colorectal Cancer
por: Zogopoulos, George, et al.
Publicado: (2008)

Detection and genomic characterization of a mammary-like adenocarcinoma
por: Grewal, Jasleen K., et al.
Publicado: (2017)

NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling
por: Britton, Heidi M., et al.
Publicado: (2021)

Chemokines and their role in airway hyper-reactivity
por: Blease, Kate, et al.
Publicado: (2000)

Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study
por: Titmuss, E., et al.
Publicado: (2023)

Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology
por: Dixon, Katherine, et al.
Publicado: (2020)

Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma
por: Ko, Jenny J., et al.
Publicado: (2018)

Role of Chemokines in the Biology of Cholangiocarcinoma
por: Caligiuri, Alessandra, et al.
Publicado: (2020)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer
por: Bridge, Jennifer A., et al.
Publicado: (2018)

Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
por: Tsukita, Yoko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ans8203n2t4mlcjnj6klpa616v